Literature DB >> 17045658

Neurocognitive deficits and disability in major depressive disorder.

Judith Jaeger1, Stefanie Berns, Sarah Uzelac, Sara Davis-Conway.   

Abstract

Disability in life functioning is an important and poorly understood consequence of major depressive disorder (MDD). Mood symptoms do not account for the magnitude of disability resulting from MDD. Impairments in several domains of neurocognitive (NC) functioning have been shown to interfere with functionality in other psychiatric populations. These deficits, also present in MDD, may play a significant role in disability experienced by many with this disorder. The aim of this study was to examine the degree to which NC deficits, independent of affective and psychotic symptoms, explain functional outcome 6 months following hospitalization for a major depressive episode. Participants with an MDD diagnosis (N=48) received NC testing and symptom ratings while in the hospital. These procedures were repeated, along with functionality ratings, 6 months later. Six-month NC performance was strongly associated with functionality ratings after covariation for residual depression. Selected NC domains tested at baseline were predictive of functionality at 6 months. These data indicate that NC deficits, at least for some MDD sufferers, play an important role in functional recovery. New treatments, whether pharmacologic or rehabilitative, may be required to help affected patients accommodate neurocognitively based performance deficits at work, at home and in the community.

Entities:  

Mesh:

Year:  2006        PMID: 17045658     DOI: 10.1016/j.psychres.2005.11.011

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  126 in total

1.  Attention/processing speed prospectively predicts social impairment 18 years later in mood disorders.

Authors:  Casey Sarapas; Stewart A Shankman; Martin Harrow; Robert N Faull
Journal:  J Nerv Ment Dis       Date:  2013-09       Impact factor: 2.254

2.  Neuroprotective evidence of alpha-lipoic acid and desvenlafaxine on memory deficit in a neuroendocrine model of depression.

Authors:  Caren Nádia Soares de Sousa; Lucas Nascimento Meneses; Germana Silva Vasconcelos; Ingridy da Silva Medeiros; Márcia Calheiros Chaves Silva; Fayçal Mouaffak; Oussama Kebir; Cláudio Manuel Gonçalves da Silva Leite; Manoel Cláudio Azevedo Patrocinio; Danielle Macedo; Silvânia Maria Mendes Vasconcelos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-07       Impact factor: 3.000

3.  Improving Health Outcomes for Patients with Depression: A Population Health Imperative. Report on an Expert Panel Meeting.

Authors:  Janice L Clarke; Alexis Skoufalos; Alice Medalia; A Mark Fendrick
Journal:  Popul Health Manag       Date:  2016-09       Impact factor: 2.459

Review 4.  Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms.

Authors:  Benji T Kurian; Tracy L Greer; Madhukar H Trivedi
Journal:  Expert Rev Neurother       Date:  2009-07       Impact factor: 4.618

Review 5.  Defining and measuring functional recovery from depression.

Authors:  Tracy L Greer; Benji T Kurian; Madhukar H Trivedi
Journal:  CNS Drugs       Date:  2010-04       Impact factor: 5.749

Review 6.  Specifying the neuropsychology of affective disorders: clinical, demographic and neurobiological factors.

Authors:  Thomas Beblo; Grant Sinnamon; Bernhard T Baune
Journal:  Neuropsychol Rev       Date:  2011-06-10       Impact factor: 7.444

7.  Domain-specific impairment in cognitive control among remitted youth with a history of major depression.

Authors:  Amy T Peters; Rachel H Jacobs; Natania A Crane; Kelly A Ryan; Sara L Weisenbach; Olusola Ajilore; Melissa Lamar; Michelle T Kassel; Laura B Gabriel; Amy E West; Jon-Kar Zubieta; Scott A Langenecker
Journal:  Early Interv Psychiatry       Date:  2015-07-14       Impact factor: 2.732

8.  Increased neural activity during overt and continuous semantic verbal fluency in major depression: mainly a failure to deactivate.

Authors:  Heidelore Backes; Bruno Dietsche; Arne Nagels; Mirjam Stratmann; Carsten Konrad; Tilo Kircher; Axel Krug
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-02-21       Impact factor: 5.270

Review 9.  Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model.

Authors:  Amanda R Mathew; Lee Hogarth; Adam M Leventhal; Jessica W Cook; Brian Hitsman
Journal:  Addiction       Date:  2016-10-26       Impact factor: 6.526

10.  Cognitive functioning in major depression--a summary.

Authors:  Asa Hammar; Guro Ardal
Journal:  Front Hum Neurosci       Date:  2009-09-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.